Prestige Consumer Healthcare Inc. continues relying on a more limited product portfolio than larger competitors in the consumer health space, but the US firm’s results show it’s becoming more like its competitors when it comes to international revenues.
Prestige Consumer Healthcare Grows Global View
Overall revenues up 2.6% for October-December to $282.7m as, for second consecutive quarter, PCH reported international sales driving growth. International grew nearly 20% to $46.2m, while North America sales were down for second straight period.
